From the category archives:

Parkinson's disease

Caffeine – Nature’s Own Wonder Drug

October 4, 2009

Much has been said and written about caffeine over the past half century. There have been over 20,000 studies conducted looking at the various effects and benefits of caffeine over this period of time. Numerous studies have demonstrated the tremendous health benefits that can be derived from regular daily [...]

Read the full article →

Relief From Parkinson Disease Freezing & Off Time

October 8, 2008

Parkinson’s disease is the second most common neurodegenerative disorder, just behind Alzheimer’s disease. Parkinson’s disease is characterized by specific clinical symptoms including rigidity (stiffness), slowness of movement, unsteadiness (gait imbalance) and tremor. For the accurate diagnosis of Parkinson’s disease to be made, a patient needs to have 3 of the 4 major symptoms of the [...]

Read the full article →

Health Benefits From Omega 3 Fish Oil

August 7, 2008

There are many studies that have shown excellent health benefits from taking omega 3 type fish oil. Omega 3 oils are found in fish oils, flax seed and several vegetable oils including canola, soybean and olive oils. There are different components to these oils that provide health benefits. The DHA and EPA oils in fish [...]

Read the full article →

Parkinson’s Disease May Benefit From Early Deep Brain Stimulation

July 10, 2008

Recent studies have suggested that qualifying Parkinson patients benefit from earlier treatment with deep brain stimulation, as reported in Clinical Neurology News. The study indicates that younger Parkinson disease patients are more likely to benefit from early brain stimulator treatment. There is information that may suggest that this therapy may have a protective effect in [...]

Read the full article →

Neupro Patch for Parkinson’s Disease Recalled by FDA

May 13, 2008

Neupro patches were approved by the FDA for Parkinson’s disease treatment in September 2007. They proved to be very effective in the control of Parkinson symptoms, as compared to the effects of other dopamine agonists including Mirapex and Requip. Unfortunately, in March, the FDA recalled Neupro due to problem with the patch delivery of the [...]

Read the full article →

FDA Approves New Alzheimer’s Medication Patch

September 24, 2007

The FDA has recently approved the dementia fighting drug Exelon in a patch form. The new formulation, Transdermal Exelon, offers patients a new and unique way to get medication which can help with improving cognitive function and slow down memory loss in patients suffering from Alzheimer’s disease. The new patch is also FDA approved for [...]

Read the full article →

New Treatment Options for Parkinson’s Disease

August 16, 2007

The FDA has approved a new medication therapy for the treatment of Parkinson’s disease. The new drug is rotigotine (Neupro), which is in the family of dopamine agonists. Dopamine agonists mimic the effects of levodopa (Sinemet) without having to go through chemical transformation. Other dopamine agonists include Mirapex and Requip. Neupro is different in that [...]

Read the full article →

Tremor – Not Everything That Shakes is Parkinson’s Disease

April 30, 2007

Essential tremor is a common disorder than is characterized by involuntary shaking of the head, jaw, hands or legs. It is estimated that there are 5-10 million affected individuals in the United States. Unfortunately, many patients are incorrectly diagnosed as having Parkinson’s disease when they actually have a form of essential tremor (ET). ET tends [...]

Read the full article →

Deep Brain Stimulation – Tremor & Parkinson’s Disease Control

September 30, 2006

Deep brain stimulation is an innovative way to control severe tremor or some of the motor symptoms of Parkinson’s disease. This medical device was approved by the FDA in 1997 for treatment of patients with severe tremor that was not controlled by medications. A few years later, it was approved for treatment of Parkinson tremor [...]

Read the full article →

New Parkinson Medication Approved by the FDA

September 27, 2006

The FDA recently approved a new Parkinson medication for use in patients that are having problems with off time and freezing. The new drug is called Zelapar. It is a rapidly dissolving tablet whose active ingredient is selegeline. Many of you may have tried selegiline in the past (marketed as Eldepryl.) The new [...]

Read the full article →